Endo Usa, Inc.
Malvern, PA
- UEI
- D739PJVW5JF9
- CAGE
- 9V3B6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 9 Great Valley Pkwy, Malvern, PA 19355, USA
- Website
- endo.com
- Founded
- 1997
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| DOD transfer awards | Office of the Assistant Secretary for Preparedness and Response | $61,822,336 |
About Endo Usa, Inc.
Endo Usa, Inc. is a for-profit corporate entity registered in SAM.gov that specializes in manufacturing pharmaceutical and medical products for federal government agencies. The company is primarily focused on developing medical countermeasures, pharmaceuticals, and advanced research solutions across multiple healthcare domains. Its recent federal registration indicates a robust capability to provide critical medical and pharmaceutical products to various government healthcare systems.
Through federal grant awards, Endo Usa, Inc. has been actively engaged in advanced biomedical research and development, particularly with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). Its most significant recent grant is a $61.8 million cooperative agreement focused on developing medical countermeasures for public health emergencies and biodefense. The project, running from September 2024 to November 2035, aims to advance research on vaccines, therapeutics, diagnostics, and medical products addressing chemical, biological, radiological, nuclear threats, pandemic influenza, and emerging infectious diseases.
Endo Usa, Inc. holds multiple Federal Supply Schedule (FSS) contract IDVs with the Department of Veterans Affairs, specifically with Veterans Integrated Service Network 12. These contracts, valued at $442 million and $264 million respectively, enable the VA to purchase pharmaceuticals, drugs, and hematology-related products. The contracts, both multiple-award vehicles under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, have performance periods extending to April 2026 and September 2025. These IDVs demonstrate the company's capacity to provide a wide range of pharmaceutical products to support healthcare services for veteran populations, with no specific set-aside designations limiting competition.
Contract vehicles
Quick answers
What is Endo Usa, Inc.'s UEI?
Endo Usa, Inc.'s Unique Entity ID (UEI) in SAM.gov is D739PJVW5JF9.
What is Endo Usa, Inc.'s CAGE code?
Endo Usa, Inc.'s CAGE code is 9V3B6.
What is Endo Usa, Inc.'s primary NAICS code?
Endo Usa, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Endo Usa, Inc. located?
Endo Usa, Inc.'s physical address in SAM.gov is 9 Great Valley Pkwy, Malvern, PA 19355, USA.
Is Endo Usa, Inc. registered in SAM.gov?
Yes. Endo Usa, Inc.'s SAM.gov registration is active through January 3, 2027.
Which contract vehicles does Endo Usa, Inc. hold?
Endo Usa, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Endo Usa, Inc.'s most recent federal award?
Endo Usa, Inc.'s most recent federal grant award is DOD transfer awards (IDSEP240074), from Office of the Assistant Secretary for Preparedness and Response, on September 12, 2024.
On GovTribe
See Endo Usa, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors